Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€159.05

€159.05

-0.280%
-0.45
-0.280%
€203.65
 
12.12.25 / Tradegate WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for ICON

sharewise wants to provide you with the best news and tools for ICON, so we directly link to the best financial data sources.

News

3 Healthcare Pathbreakers With Long-Term Tailwinds
3 Healthcare Pathbreakers With Long-Term Tailwinds

In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals

LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million

According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (NASDAQ:ICLR) by selling 16,096 shares. The transaction was valued at $2.58 million

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the

ICON plc Schedules Second Quarter 2025 Earnings Conference Call
ICON plc Schedules Second Quarter 2025 Earnings Conference Call


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025